Skip to content
OpenCongress is in beta. We'd love your feedback!Share feedback
Hearing · Health · House of RepresentativesLikely held · Jul 15, 2026

Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.

Committee
Health
Date
Jul 15, 2026 · 10:15
Location
2123, Rayburn House Office Building
Witnesses
5
Likely held

Inferred from the date. No official record confirms this meeting took place.

Location

2123, Rayburn House Office Building

Committee

Health

Congress

119th

View on Congress.gov

Video

Witnesses(5)

NamePositionLinks
Dr. Aaron KowalskiCEO, Breakthrough T1D
Dr. Cynthia VerstPresident, Design and Delivery Innovation, R&D Solutions, IQVIA
Dr. Thomas HwangAssistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School
Mr. Thomas BollykyBloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council
Ms. Susan WincklerCEO, Reagan-Udall Foundation for the FDA